PAR 1.17% $1.27 paradigm biopharmaceuticals limited..

The Future

  1. 15 Posts.
    lightbulb Created with Sketch. 6
    I have just finished Loading up on this stock and had to post about my excitement for it's potential. I work in an associated field and people are constantly asking about the option of injectable therapy for Arthritis. It make intuitive sense to people, especially farmers, tradies etc that something can be put into a joint and improve their function and pain. Although Pentosan isn't a product that involves simple things like shock absorption or direct analgesia/numbing of pain that people can simply understand it still will be very appealing to those who have arthritis who think along those lines. Joint arthroplasty/fusion/debridement/lavage are all unsatisfactory to so many patients and there are already proven business models of injectables for Arthritis using everything from steroids, patient sourced blood products, synthetic glycosaminoglycans among others that are (looking at recent results) little better than placebo and very unlikely to be looked upon favourably in comparison to Pentosan in the coming years.

    Can't wait for what the future holds
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Mkt cap ! $244.1M
Open High Low Value Volume
$1.29 $1.30 $1.26 $694.2K 545.4K

Buyers (Bids)

No. Vol. Price($)
1 1058 $1.27

Sellers (Offers)

Price($) Vol. No.
$1.28 3000 1
View Market Depth
Last update - 16.10pm 26/06/2019 (20 minute delay) ?
-0.015 ( 1.01 %)
Open High Low Volume
$1.28 $1.28 $1.27 8676
Last updated 15.59pm 26/06/2019 (live) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.